Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The letter

Your summary is well stated and, IMO, accurate.

As for the shareholder letter, it is not my style at all. I control my own current and future stock holdings without regard to what naysayers and hypesters post on a message board. For me, somewhere in the middle is a more reasonable point-of-view.

I would prefer to speak to someone (CEO, President, IR) directly on the phone or via email. I do this with EDIg and other stocks I own. I have not tried to contact Mr. Turley as I believe the company communication and their hands are tied with mouths wired shut at this time.

I have to agree with SGE on this one as well. If I were to participate, I would insist on reading what I am agreeing with PRIOR to it being sent and my sahres being included. I do not believe Ron or anyone else has malious motives in any way, I just want to know what is stated.

However, I must state that Greeneyes brings up a good point about the timing. Why now? Why not after the company own deadline in April?

John

Share
New Message
Please login to post a reply